• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非层次相关造血干细胞启动的替代性血小板分化途径。

Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells.

机构信息

Haematopoietic Stem Cell Biology Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

出版信息

Nat Immunol. 2024 Jun;25(6):1007-1019. doi: 10.1038/s41590-024-01845-6. Epub 2024 May 30.

DOI:10.1038/s41590-024-01845-6
PMID:38816617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11147777/
Abstract

Rare multipotent stem cells replenish millions of blood cells per second through a time-consuming process, passing through multiple stages of increasingly lineage-restricted progenitors. Although insults to the blood-forming system highlight the need for more rapid blood replenishment from stem cells, established models of hematopoiesis implicate only one mandatory differentiation pathway for each blood cell lineage. Here, we establish a nonhierarchical relationship between distinct stem cells that replenish all blood cell lineages and stem cells that replenish almost exclusively platelets, a lineage essential for hemostasis and with important roles in both the innate and adaptive immune systems. These distinct stem cells use cellularly, molecularly and functionally separate pathways for the replenishment of molecularly distinct megakaryocyte-restricted progenitors: a slower steady-state multipotent pathway and a fast-track emergency-activated platelet-restricted pathway. These findings provide a framework for enhancing platelet replenishment in settings in which slow recovery of platelets remains a major clinical challenge.

摘要

稀有多能干细胞通过一个耗时的过程每秒补充数百万个血细胞,经历多个阶段,逐渐成为谱系受限的祖细胞。虽然血液生成系统受到损伤突出表明需要更快地从干细胞中补充血液,但已建立的造血模型仅暗示每个血细胞谱系都需要一条强制性分化途径。在这里,我们建立了一个在补充所有血细胞谱系的不同干细胞和几乎仅补充血小板的干细胞之间的非层次关系,血小板是止血所必需的谱系,在先天和适应性免疫系统中都有重要作用。这些不同的干细胞使用细胞上、分子上和功能上独立的途径来补充分子上不同的巨核细胞限制祖细胞:一个较慢的稳态多能途径和一个快速通道应急激活的血小板限制途径。这些发现为增强血小板补充提供了一个框架,在血小板恢复缓慢仍然是一个主要临床挑战的情况下,这是非常有意义的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/9a3f50f96923/41590_2024_1845_Fig18_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/d22257f3f515/41590_2024_1845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/923bc8dfba7f/41590_2024_1845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/0e177898d367/41590_2024_1845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/3a9f54eba20e/41590_2024_1845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/992f3602a6eb/41590_2024_1845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/9250054b68e2/41590_2024_1845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/3845acdcf4af/41590_2024_1845_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/a14efe2d6bc4/41590_2024_1845_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/ec393cfff1e0/41590_2024_1845_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/f09f621e6387/41590_2024_1845_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/9ce84c1955a1/41590_2024_1845_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/1cf301d6db01/41590_2024_1845_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/51e7842c87db/41590_2024_1845_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/c85ee4a33502/41590_2024_1845_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/dc6c6ee467b7/41590_2024_1845_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/25a12d8b2dca/41590_2024_1845_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/8eb04e3ac0b6/41590_2024_1845_Fig17_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/9a3f50f96923/41590_2024_1845_Fig18_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/d22257f3f515/41590_2024_1845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/923bc8dfba7f/41590_2024_1845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/0e177898d367/41590_2024_1845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/3a9f54eba20e/41590_2024_1845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/992f3602a6eb/41590_2024_1845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/9250054b68e2/41590_2024_1845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/3845acdcf4af/41590_2024_1845_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/a14efe2d6bc4/41590_2024_1845_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/ec393cfff1e0/41590_2024_1845_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/f09f621e6387/41590_2024_1845_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/9ce84c1955a1/41590_2024_1845_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/1cf301d6db01/41590_2024_1845_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/51e7842c87db/41590_2024_1845_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/c85ee4a33502/41590_2024_1845_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/dc6c6ee467b7/41590_2024_1845_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/25a12d8b2dca/41590_2024_1845_Fig16_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/8eb04e3ac0b6/41590_2024_1845_Fig17_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d31/11147777/9a3f50f96923/41590_2024_1845_Fig18_ESM.jpg

相似文献

1
Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells.非层次相关造血干细胞启动的替代性血小板分化途径。
Nat Immunol. 2024 Jun;25(6):1007-1019. doi: 10.1038/s41590-024-01845-6. Epub 2024 May 30.
2
Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells.多能造血干细胞的层次相关谱系限制命运。
Nature. 2018 Feb 1;554(7690):106-111. doi: 10.1038/nature25455. Epub 2018 Jan 3.
3
From Hematopoietic Stem Cells to Platelets: Unifying Differentiation Pathways Identified by Lineage Tracing Mouse Models.从造血干细胞到血小板:谱系追踪小鼠模型鉴定的统一分化途径。
Cells. 2024 Apr 19;13(8):704. doi: 10.3390/cells13080704.
4
New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors.造血祖细胞向巨核细胞分化的新见解。
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1288-1300. doi: 10.1161/ATVBAHA.119.312129. Epub 2019 May 2.
5
[Hematopoietic Stem Cells Differentiate into the Megakaryocyte Lineage--Review].[造血干细胞向巨核细胞谱系的分化——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Jun;28(3):1044-1048. doi: 10.19746/j.cnki.issn.1009-2137.2020.03.054.
6
The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis.巨核细胞系起源于成血管细胞前体,是原始造血和定形造血的一个组成部分。
Blood. 2007 Feb 15;109(4):1433-41. doi: 10.1182/blood-2006-06-031898. Epub 2006 Oct 24.
7
Clonal and Quantitative In Vivo Assessment of Hematopoietic Stem Cell Differentiation Reveals Strong Erythroid Potential of Multipotent Cells.体内克隆和定量评估造血干细胞分化,揭示多能细胞的强烈红细胞生成潜力。
Stem Cell Reports. 2019 Apr 9;12(4):801-815. doi: 10.1016/j.stemcr.2019.02.007. Epub 2019 Mar 21.
8
Clonal analysis of lineage fate in native haematopoiesis.对天然造血中谱系命运的克隆分析。
Nature. 2018 Jan 11;553(7687):212-216. doi: 10.1038/nature25168. Epub 2018 Jan 3.
9
Direct megakaryopoiesis.直接巨核细胞生成
Curr Opin Hematol. 2025 Jul 1;32(4):213-220. doi: 10.1097/MOH.0000000000000871. Epub 2025 Apr 21.
10
Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors.炎症诱导的造血干细胞样巨核细胞前体细胞驱动的应急性巨核细胞生成
Cell Stem Cell. 2015 Oct 1;17(4):422-34. doi: 10.1016/j.stem.2015.07.007. Epub 2015 Aug 20.

引用本文的文献

1
Haematopoietic ageing in health and lifespan.健康与寿命中的造血衰老
Nat Cell Biol. 2025 Aug 25. doi: 10.1038/s41556-025-01739-1.
2
Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation.生殖系Jak2-R1063H突变干扰正常造血发育,增加血栓形成和白血病转化风险。
Leukemia. 2025 Aug 21. doi: 10.1038/s41375-025-02737-w.
3
Stable platelet production via the bypass pathway explains long-term hematopoietic stem cell reconstitution.通过旁路途径实现稳定的血小板生成解释了长期造血干细胞重建的原因。

本文引用的文献

1
A time- and single-cell-resolved model of murine bone marrow hematopoiesis.一个时间和单细胞分辨的鼠骨髓造血模型。
Cell Stem Cell. 2024 Feb 1;31(2):244-259.e10. doi: 10.1016/j.stem.2023.12.001. Epub 2024 Jan 5.
2
Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner.血管周龛细胞感知血小板减少,并以白细胞介素-1(IL-1)依赖的方式激活造血干细胞。
Nat Commun. 2023 Sep 28;14(1):6062. doi: 10.1038/s41467-023-41691-y.
3
Epigenetic programming defines haematopoietic stem cell fate restriction.
iScience. 2025 Apr 29;28(6):112547. doi: 10.1016/j.isci.2025.112547. eCollection 2025 Jun 20.
4
New insights into the generation and function of megakaryocytes in health and disease.健康与疾病状态下巨核细胞生成及功能的新见解
Haematologica. 2025 Jul 1;110(7):1500-1512. doi: 10.3324/haematol.2024.287236. Epub 2025 Mar 27.
5
DNMT3A regulates murine megakaryocyte-biased hematopoietic stem cell fate decisions.DNMT3A调控小鼠巨核细胞偏向性造血干细胞的命运决定。
Blood Adv. 2025 May 13;9(9):2285-2299. doi: 10.1182/bloodadvances.2024015061.
6
Deciphering the Complexities of Adult Human Steady State and Stress-Induced Hematopoiesis: Progress and Challenges.解读成人人类稳态和应激诱导造血的复杂性:进展与挑战
Int J Mol Sci. 2025 Jan 14;26(2):671. doi: 10.3390/ijms26020671.
7
Hematopoietic Stem Cell Fates and the Cellular Hierarchy of Mammalian Hematopoiesis: from Transplantation Models to New Insights from in Situ Analyses.造血干细胞命运与哺乳动物造血的细胞层级:从移植模型到原位分析的新见解
Stem Cell Rev Rep. 2025 Jan;21(1):28-44. doi: 10.1007/s12015-024-10782-8. Epub 2024 Sep 2.
8
Preservation of a youthful path to evergreen platelets?保留通往永葆青春血小板的年轻途径?
Cell Res. 2025 Feb;35(2):93-94. doi: 10.1038/s41422-024-01015-1.
表观遗传编程定义了造血干细胞命运的限制。
Nat Cell Biol. 2023 Jun;25(6):812-822. doi: 10.1038/s41556-023-01137-5. Epub 2023 May 1.
4
Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications.血小板及其在止血和血栓形成中的作用——从生理学到病理生理学及治疗意义。
Int J Mol Sci. 2022 Oct 23;23(21):12772. doi: 10.3390/ijms232112772.
5
Adult murine hematopoietic stem cells and progenitors: an update on their identities, functions, and assays.成年鼠造血干细胞和祖细胞:其特性、功能和检测方法的最新进展。
Exp Hematol. 2022 Dec;116:1-14. doi: 10.1016/j.exphem.2022.10.005. Epub 2022 Oct 23.
6
Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus.血小板LGALS3BP作为系统性红斑狼疮中髓系炎症的介质
Arthritis Rheumatol. 2023 May;75(5):711-722. doi: 10.1002/art.42382. Epub 2023 Mar 14.
7
Fate mapping of hematopoietic stem cells reveals two pathways of native thrombopoiesis.造血干细胞的命运图谱揭示了两种内源性血小板生成途径。
Nat Commun. 2022 Aug 3;13(1):4504. doi: 10.1038/s41467-022-31914-z.
8
Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification.简化的鼠多能祖细胞分离方案:建立多能祖细胞鉴定的共识方法。
Exp Hematol. 2021 Dec;104:55-63. doi: 10.1016/j.exphem.2021.09.007. Epub 2021 Oct 11.
9
Molecular architecture of the developing mouse brain.发育中老鼠大脑的分子结构。
Nature. 2021 Aug;596(7870):92-96. doi: 10.1038/s41586-021-03775-x. Epub 2021 Jul 28.
10
Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis.单细胞分析倍性和转录组揭示了小鼠巨核细胞生成中的功能和空间差异。
Blood. 2021 Oct 7;138(14):1211-1224. doi: 10.1182/blood.2021010697.